White Paper

White Paper: Outsourcing: A Rapid, Cost-Effective Option For Electronic Submissions

Source: Beckloff Associates

Pharmaceutical and biotech sponsor organizations are in increasing numbers making the switch from paper to electronic format for their marketing applications to FDA. The decision to adopt the electronic Common Technical Document (eCTD) submission format is a strategic one, offering the sponsor these important benefits:

  1. a greatly enhanced ability to efficiently organize, prepare, and manage submission content
  2. the opportunity for streamlined interactions with agency reviewers,
  3. a potentially more efficient and thorough agency review.

Barriers to adoption typically include:

  1. costs (initial capital: $200K- $300K and annual expense: $100 - $200K) of building, validating and operating an electronic publishing system,
  2. effort and time to learn and understand the regulatory requirements and to develop the organizational competency to efficiently produce compliant eCTD submissions.
VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: